Howton David T, Chief Operating Officer of Solid Biosciences Inc. ($SLDB), sold shares on the open market four times in the last 365 days, totaling about $434 thousand. His most recent sale occurred on February 18, 2026. These sales rank 6,783rd among 11,678 individual insiders in our database, where the average sale amount is 8.6 million and the average number of transactions is 6.4. Howton David T made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | S | Common Stock | 7469 | $5.82 | 105,077.0000 | 94,417,746 | 6.64% | 0.01% |
| Feb. 13, 2026 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | M | Common Stock | 14687 | $0.00 | 112,546.0000 | 94,417,746 | 15.01% | 0.02% |
| Feb. 13, 2026 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | M | Restricted Stock Units | 14687 | $0.00 | 29,376.0000 | 94,417,746 | 33.33% | 0.02% |
| Feb. 4, 2026 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | S | Common Stock | 18894 | $6.44 | 97,859.0000 | 94,417,746 | 16.18% | 0.02% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | A | Employee Stock Option (Right to Buy) | 210200 | $0.00 | 210,200.0000 | 94,417,746 | 9999.99% | 0.22% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | M | Performance Stock Units | 79341 | $0.00 | 0.0000 | 94,417,746 | 100.00% | 0.08% |
| Feb. 2, 2026 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | S | Common Stock | 37771 | $6.44 | 116,753.0000 | 94,417,746 | 24.44% | 0.04% |
| Jan. 31, 2026 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | M | Common Stock | 42275 | $0.00 | 154,254.0000 | 94,417,746 | 37.75% | 0.04% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | M | Common Stock | 79341 | $0.00 | 112,249.0000 | 94,417,746 | 241.10% | 0.08% |
| Jan. 31, 2026 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | M | Restricted Stock Units | 42275 | $0.00 | 126,825.0000 | 94,417,746 | 25.00% | 0.04% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | A | Restricted Stock Units | 105100 | $0.00 | 105,100.0000 | 94,417,746 | 9999.99% | 0.11% |
| Dec. 3, 2025 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | S | Common Stock | 4932 | $5.11 | 32,908.0000 | 94,417,746 | 13.03% | 0.01% |
| Dec. 2, 2025 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | M | Common Stock | 13051 | $0.00 | 37,840.0000 | 94,417,746 | 52.65% | 0.01% |
| Dec. 2, 2025 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | M | Restricted Stock Units | 13051 | $0.00 | 13,052.0000 | 94,417,746 | 50.00% | 0.01% |
| Aug. 14, 2025 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | A | Employee Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 40,816,694 | 9999.99% | 0.37% |
| Aug. 14, 2025 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | A | Restricted Stock Units | 75000 | $0.00 | 75,000.0000 | 40,816,694 | 9999.99% | 0.18% |
| Feb. 13, 2025 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | M | Restricted Stock Units | 14687 | $0.00 | 44,063.0000 | 40,816,694 | 25.00% | 0.04% |
| Feb. 14, 2025 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | S | Common Stock | 5561 | $3.96 | 24,789.0000 | 40,816,694 | 18.32% | 0.01% |
| Feb. 13, 2025 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | M | Common Stock | 14687 | $0.00 | 30,350.0000 | 40,816,694 | 93.77% | 0.04% |
| Jan. 31, 2025 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | A | Restricted Stock Units | 169100 | $0.00 | 169,100.0000 | 40,816,694 | 9999.99% | 0.41% |
| Dec. 2, 2024 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | M | Common Stock | 13051 | $0.00 | 20,735.0000 | 41,443,317 | 169.85% | 0.03% |
| Dec. 2, 2024 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | M | Restricted Stock Units | 13051 | $0.00 | 26,103.0000 | 41,443,317 | 33.33% | 0.03% |
| Dec. 3, 2024 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | S | Common Stock | 5072 | $5.60 | 15,663.0000 | 41,443,317 | 24.46% | 0.01% |
| Feb. 13, 2024 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | A | Restricted Stock Units | 58750 | $0.00 | 58,750.0000 | 19,884,007 | 9999.99% | 0.30% |
| Feb. 13, 2024 | Solid Biosciences Inc. | $SLDB | Howton David T | Chief Operating Officer | A | Employee Stock Option (Right to Buy) | 117500 | $0.00 | 117,500.0000 | 19,884,007 | 9999.99% | 0.59% |